Clinical Trials Browser

NETWORK × Temozolomide × Other hematologic neoplasm × Clear all

NCT00083070 2014-02-20

Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

Phase 1 Completed

LymphoidOther hematologic neoplasm

Blast Crisis, Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma